{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T19:04:05Z","timestamp":1775588645267,"version":"3.50.1"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>Prenatal genetic testing can be divided into two categories: screening and diagnostic. This article will focus on reviewing prenatal genetic screening tests.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>Cell-free DNA (cfDNA) is a new prenatal genetic screening test with a high degree of accuracy for identifying certain genetic conditions like trisomy 21, 18, and 13. However, cfDNA has also been applied in the screening of other genetic conditions without similar research support.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>Prenatal genetic screening evaluates at risk pregnancies - including both carrier screening, which can be done at any point in a person's life, and aneuploidy screening, which is done during pregnancy. Within screening, there is a new noninvasive technology that has revolutionized prenatal screening called cfDNA testing. Compared to previous methods, this technology is easier to administer and more accurate for certain genetic conditions. However, cfDNA has also been applied to test for less common genetic conditions without efficacious research support. In this time of expansion in genetic testing, it is important that providers educate themselves on the research support behind each type of genetic test. It is vital that professional organizations continuously update their testing approach to match these rapidly evolving technologies and the patient population they serve.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mop.0000000000001172","type":"journal-article","created":{"date-parts":[[2022,9,9]],"date-time":"2022-09-09T02:00:47Z","timestamp":1662688847000},"page":"544-552","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["Prenatal genetic testing 1: screening tests"],"prefix":"10.1097","volume":"34","author":[{"given":"Morgan","family":"Jenkins","sequence":"first","affiliation":[{"name":"University of Alabama at Birmingham Heersink School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela R.","family":"Seasely","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Division of Maternal Fetal Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akila","family":"Subramaniam","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Division of Maternal Fetal Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2022,9,9]]},"reference":[{"key":"R1-20250730","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1159\/000294191","article-title":"Communicating genetic and genomic information: health literacy and numeracy considerations","volume":"14","author":"Lea","year":"2011","journal-title":"Public Health Genomics"},{"key":"R2-20250730","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1053\/j.semperi.2018.07.019","article-title":"Prenatal genetic carrier screening in the genomic age","volume":"42","author":"Gregg","year":"2018","journal-title":"Semin Perinatol"},{"key":"R3-20250730","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ogc.2017.10.005","article-title":"Expanded carrier screening","volume":"45","author":"Gregg","year":"2018","journal-title":"Obstet Gynecol Clin North Am"},{"key":"R5-20250730","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1038\/s41436-021-01203-z","article-title":"Screening for autosomal recessive and X-linked conditions during pregnancy and preconception: a practice resource of the American College of Medical Genetics and Genomics (ACMG)","volume":"23","author":"Gregg","year":"2021","journal-title":"Genet Med"},{"key":"R6-20250730","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1097\/AOG.0000000000000666","article-title":"Expanded carrier screening in reproductive medicine\u2014points to consider","volume":"125","author":"Edwards","year":"2015","journal-title":"Obstet Gynecol"},{"key":"R7-20250730","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/AOG.0000000000001952","article-title":"Carrier screening for genetic conditions","volume":"129","year":"2017","journal-title":"Obstet Gynecol"},{"key":"R8-20250730","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1038\/s41436-020-0807-4","article-title":"Clinical experience with carrier screening in a general population: support for a comprehensive pan-ethnic approach","volume":"22","author":"Westemeyer","year":"2020","journal-title":"Genet Med"},{"key":"R9-20250730","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1097\/AOG.0000000000001951","article-title":"Carrier screening in the age of genomic medicine","volume":"129","year":"2017","journal-title":"Obstet Gynecol"},{"key":"R11-20250730","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/s41436-020-0822-5","article-title":"CFTR variant testing: a technical standard of the American College of Medical Genetics and Genomics (ACMG)","volume":"22","author":"Deignan","year":"2020","journal-title":"Genet Med"},{"key":"R12-20250730","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/01.GIM.0000139506.11694.7C","article-title":"Cystic fibrosis population carrier screening: 2004 revision of American College of Medical Genetics Mutation Panel","volume":"6","author":"Watson","year":"2004","journal-title":"Genet Med"},{"key":"R14-20250730","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.jmoldx.2020.03.001","article-title":"Carrier screening and prenatal diagnosis for spinal muscular atrophy in 13,069 Chinese pregnant women","volume":"22","author":"Zhang","year":"2020","journal-title":"J Mol Diagn"},{"key":"R15-20250730","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1097\/AOG.0b013e31817d252f","article-title":"Ethical issues in genetic testing","volume":"111","year":"2008","journal-title":"Obstetr Gynecol"},{"key":"R16-20250730","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/pd.4784","article-title":"Prenatal reflex DNA screening for down syndrome: enhancing the screening performance of the initial first trimester test","volume":"36","author":"Wald","year":"2016","journal-title":"Prenatal Diagn"},{"key":"R18-20250730","doi-asserted-by":"crossref","first-page":"E270","DOI":"10.1002\/ajh.26570","article-title":"Validation of single-gene noninvasive prenatal testing for sickle cell disease","volume":"97","author":"Westin","year":"2022","journal-title":"Am J Hematol"},{"key":"R19-20250730","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1053\/j.semperi.2015.11.006","article-title":"Screening for fetal aneuploidy","volume":"40","author":"Rink","year":"2016","journal-title":"Semin Perinatol"},{"key":"R20-20250730","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1097\/AOG.0000000000004084","volume":"136","year":"2020","journal-title":"Am Coll Obstetr Gynecol"},{"key":"R21-20250730","first-page":"1323","article-title":"Maternal serum alpha-fetoprotein measurement in antenatal screening for anencephaly and spina bifida in early pregnancy","volume":"1","author":"Wald","year":"1977","journal-title":"Lancet"},{"key":"R22-20250730","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1056\/NEJMoa025273","article-title":"First-trimester screening for trisomies 21 and 18","volume":"349","author":"Wapner","year":"2003","journal-title":"N Engl J Med"},{"key":"R23-20250730","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa043693","article-title":"First-trimester screening, or both, for Down's syndrome","volume":"353","author":"Malone","year":"2005","journal-title":"N Engl J Med"},{"key":"R24-20250730","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.ogc.2017.02.004","article-title":"Prenatal Diagnosis: screening and diagnostic tools","volume":"44","author":"Carlson","year":"2017","journal-title":"Obstet Gynecol Clin N Am"},{"key":"R25-20250730","first-page":"516","article-title":"Prenatal chromosomal microarray analysis in 2466 fetuses with ultrasonographic soft markers: a prospective cohort study","volume":"224","author":"Hu","year":"2021","journal-title":"Am J Obstet Gynecol"},{"key":"R27-20250730","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/uog.17246","article-title":"Systematic review of first-trimester ultrasound screening for detection of fetal structural anomalies and factors that affect screening performance","volume":"50","author":"Karim","year":"2017","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R28-20250730","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/gim.2013.29","article-title":"Noninvasive prenatal screening for fetal aneuploidy 2016 update: a position statement of the American College of Medical Genetics and Genomics","volume":"15","author":"Gregg","year":"2016","journal-title":"Genet Med"},{"key":"R29-20250730","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/OGX.0000000000000342","article-title":"Cell-free DNA screening: complexities and challenges of clinical implementation","volume":"71","author":"Grace","year":"2016","journal-title":"Obstet Gynecol Surv"},{"key":"R30-20250730","doi-asserted-by":"crossref","first-page":"A1","DOI":"10.1530\/REP-19-0591","article-title":"Preimplantation genetic testing: noninvasive prenatal testing for aneuploidy, copy-number variants and single-gene disorders","volume":"160","author":"Shaw","year":"2020","journal-title":"Reproduction"},{"key":"R31-20250730","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/uog.17484","article-title":"Analysis of cell-free DNA in maternal blood in screening for aneuploidies: updated meta-analysis","volume":"50","author":"Gil","year":"2017","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R32-20250730","doi-asserted-by":"crossref","first-page":"S437","DOI":"10.1016\/j.ajog.2021.11.728","article-title":"Factors that affect cell-free DNA fetal fraction in twin gestations","volume":"226","author":"Dugoff","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"R33-20250730","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1002\/uog.20284","article-title":"Screening for trisomies by cfDNA testing of maternal blood in twin pregnancy: update of the fetal medicine foundation results and meta-analysis","volume":"53","author":"Gil","year":"2019","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R34-20250730","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1002\/uog.20290","article-title":"First-trimester screening for trisomies by cfDNA testing of maternal blood in singleton and twin pregnancies: factors affecting test failure","volume":"53","author":"Galeva","year":"2019","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R35-20250730","doi-asserted-by":"crossref","first-page":"501","DOI":"10.3390\/genes12040501","article-title":"Chances and challenges of new genetic screening technologies (NIPT) in prenatal medicine from a clinical perspective: a narrative review","volume":"12","author":"Bedei","year":"2021","journal-title":"Genes"}],"container-title":["Current Opinion in Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MOP.0000000000001172","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T18:04:49Z","timestamp":1753898689000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MOP.0000000000001172"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,9]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/mop.0000000000001172","relation":{},"ISSN":["1040-8703","1531-698X"],"issn-type":[{"value":"1040-8703","type":"print"},{"value":"1531-698X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,9]]}}}